![Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study Yu Y, Zhang Q, Zhang J, Lu S - J Can Res Ther Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study Yu Y, Zhang Q, Zhang J, Lu S - J Can Res Ther](https://www.cancerjournal.net/articles/2019/15/4/images/JCanResTher_2019_15_4_909_264294_i4.jpg)
Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study Yu Y, Zhang Q, Zhang J, Lu S - J Can Res Ther
![An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology | Laboratory Investigation An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology | Laboratory Investigation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41374-021-00536-2/MediaObjects/41374_2021_536_Fig1_HTML.png)
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology | Laboratory Investigation
![Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-019-0716-8/MediaObjects/41591_2019_716_Fig1_HTML.png)
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine
![Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6d8e24ed-aece-4976-8af5-b185e5b710fc/gr1_lrg.jpg)
Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer
![The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016950021630527X-gr2.jpg)
The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect
![MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2020/12/Fig-3-1.jpg)
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
![MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2020/12/Fig-2-1.jpg)
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
![DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3eafbcbf-f53b-4a20-aa8b-c0a33c9f5c5c/gr1_lrg.jpg)
DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology
![Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5132f241-0043-4f04-ac34-e795a10d6132/gr1_lrg.jpg)
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
![MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing](https://www.primescholars.com/articles-images/cancer-epidemiology-prevention-Integrated-Genome-Viewer-1-1-1-g001a.png)
MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing
![The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737220300608-gr3.jpg)
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect
![Introduction - Targeting METex14 NSCLC - Text Module - MET Inhibition in NSCLC - Oncology - Clinical Care Options Introduction - Targeting METex14 NSCLC - Text Module - MET Inhibition in NSCLC - Oncology - Clinical Care Options](https://www.clinicaloptions.com/-/media/oncology/programs/nsclc-metex14/module-thumbs/cco-metex14-asco-cf_thumb2.png?rev=5b312d1500fb430198a84dee8244cc96)
Introduction - Targeting METex14 NSCLC - Text Module - MET Inhibition in NSCLC - Oncology - Clinical Care Options
![A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/49717/public/49717-PB5-3767-R1.png/w300)
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research
![Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram](https://www.researchgate.net/profile/Jeremy-Stinson/publication/7374944/figure/fig2/AS:667651978309640@1536192044800/Identification-of-tumor-specific-intronic-mutations-in-Met-leading-to-exon-14-splicing.png)
Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram
![Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/88c33a30-1781-4baa-9eae-b673fc22034a/gr1_lrg.jpg)
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
![Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086418330387-gr2.jpg)
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect
![Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/df0dbf25-b023-4553-9f6b-87905379ae01/gr1.jpg)